Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic, active Epstein-Barr virus infection.

D M Maia1, A L Peace-Brewer

  • 1Dept. of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill 27599-7525, USA.

Current Opinion in Hematology
|December 23, 1999
PubMed
Summary

Chronic active Epstein-Barr virus (EBV) infection disrupts the host-virus balance, unlike typical latent infections. Research explores immune defects and viral factors, with new treatments like T-cell therapy showing promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bilateral infiltrating lobular carcinoma of the breast with osteoclast-like giant cells.

The breast journal·2001
Same author

Sex steroid receptors in Hodgkin's disease.

Leukemia & lymphoma·2001
Same author

The reliability of frozen-section diagnosis in the pathologic evaluation of Hirschsprung's disease.

The American journal of surgical pathology·2000
Same author

A survey of oral biopsies in Brazilian pediatric patients.

ASDC journal of dentistry for children·2000
Same author

Analysis of the mutant HLA-A*0201 heavy chain H74L: impaired TAP-dependent peptide loading.

Human immunology·1999
Same author

Cell cycle-associated proteins in melanotic neuroectodermal tumor of infancy.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics·1999

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Chronic active Epstein-Barr virus (EBV) infection is a rare complication of EBV, distinct from acute infectious mononucleosis.
  • In this condition, the normally balanced lifelong EBV infection is disturbed, leading to potential waxing/waning or severe illness.
  • The precise mechanisms causing this imbalance are not fully understood but likely involve complex interactions between host immunity and viral factors.

Purpose of the Study:

  • To summarize the understanding of chronic active EBV infection, including its pathogenesis and clinical presentation.
  • To review the known immunological and viral factors contributing to the disease.
  • To discuss current and emerging treatment strategies for this challenging condition.

Main Methods:

Related Experiment Videos

  • Review of existing literature on chronic active EBV infection.
  • Analysis of reported immunological defects in affected patients.
  • Examination of studies on viral gene expression in chronic active EBV infection.

Main Results:

  • Chronic active EBV infection is characterized by a perturbed host-virus equilibrium.
  • Subtle immunologic defects and enhanced viral gene expression are observed in some patients.
  • Treatment remains challenging, but novel approaches are emerging.

Conclusions:

  • The pathogenesis of chronic active EBV infection is heterogeneous, involving host and viral elements.
  • Understanding these factors is crucial for developing effective therapies.
  • Promising new treatments include etoposide-based regimens and adoptive transfer of EBV-specific cytotoxic T lymphocytes.